TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection — Phase IIb multicenter trial initiated, bringing this potential life-changing therapy closer… CISION PRNewswireSeptember 10, 2026
Press ReleaseNeolix, World's Leading Autonomous Delivery Fleet Operator, Begins First L4 Testing in Tokyo Neolix conducts its first L4 test at Tokyo Ryutsu Center (TRC, 株式会社東京流通センター)… CISION PRNewswireSeptember 10, 2026
Lufax Announces Extraordinary General Meeting on October 8, 2026 SHANGHAI, Sept. 10, 2026 /PRNewswire/ — Lufax Holding Ltd ("Lufax" or the… CISION PRNewswireSeptember 10, 2026
Press ReleaseST Engineering iDirect Advances Intelligent Satellite Operations with New AI Capabilities New capabilities for AI governance, operational control and rapid onboarding help operators… CISION PRNewswireSeptember 10, 2026
Nuritas Appoints Former Unilever North America President Kees Kruythoff as Board Chair The 30-year industry veteran brings global scaling and commercialization expertise to biotech… CISION PRNewswireSeptember 10, 2026
ECARX to Present at the Sidoti Small-Cap Investor Conference on September 24, 2026 LONDON, Sept. 10, 2026 /PRNewswire/ — ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or… CISION PRNewswireSeptember 10, 2026
Press ReleaseThe "Wynn Signature – 2026 Hypercar Exhibition" Presents: A Curation of Automotive Powerhouses in the Year of the Fire Horse More than 20 legendary hypercars gather in Macao: A spectacular showcase of speed… CISION PRNewswireSeptember 10, 2026
Press ReleaseMTE HANOI 2026 – GLOBAL TRENDS IMPACTING VIETNAM HOSPITALITY AND REAL ESTATE HO CHI MINH CITY, Vietnam, Sept. 10, 2026 /PRNewswire/ — Global challenges… CISION PRNewswireSeptember 10, 2026
